Systemic Treatments of Leishmaniasis: A Narrative Review
(ندگان)پدیدآور
Taheri, Ahmad RezaSabouri Rad, SaraMolkara, Saraنوع مدرک
TextReview
زبان مدرک
Englishچکیده
Cutaneous leishmaniasis is a prevalent parasitic infection in humans. According to the reports published in several localities across the world, leishmaniasis is an endemic disease in certain regions in Iran. Leishmaniasis is transmitted through sandfly bites and is often diagnosed through the smear examination of the affected area using a microscope. The treatments of choice for leishmaniasis involve the use of pentavalent antimony compounds, such as meglumine antimoniate and sodium stibogluconate. However, other medications have been proposed for the treatment of leishmaniasis, and there is ongoing research for effective, less harmful treatments. This narrative review aimed to summarize various systemic treatments for leishmaniasis.
کلید واژگان
Cutaneous LeishmaniasisSystemic
Treatment
شماره نشریه
3تاریخ نشر
2019-09-011398-06-10
ناشر
Mashhad University of Medical Sciencesسازمان پدید آورنده
Cutaneous Leishmaniasis Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.Cutaneous Leishmaniasis Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Resident of Dermatology, Imam Reza hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
شاپا
2345-62562345-6892




